FT : Private credit finds its next big target: investment grade debt

Private credit finds its next big target: investment grade debt
Blue-chip companies bypass banks and bond markets to borrow from industry with $1.4tn war chest

Alternative asset managers such as Apollo, KKR and Blackstone are increasingly financing blue-chip companies, as businesses look for new sources of capital to help counteract the effects of higher interest rates and a slowing economy.

The deals — including two announced this month with AT&T and PayPal — underscore the growing reach of the private credit industry as it helps companies bypass traditional banks and bond markets to raise money.

Private credit has boomed in the decade since the global financial crisis into a sector with $1.4tn in assets. Loans from private credit typically went to companies that were smaller or riskier.

Now, alternative asset managers lenders are targeting larger, more stable companies. “Private credit is going investment grade,” said Akhil Bansal, head of credit strategic solutions at Carlyle, the private equity group.

Executives said the shift was a natural outgrowth of private credit’s fundraising spree, giving managers cash to lend.
As well, most major private equity groups have bought or invested in an insurance company in the past five years, drawing in hundreds of billions of premiums to invest.
Supercharging the push has been Apollo, whose insurer Athene has amassed nearly $260bn in capital — roughly half of Apollo’s assets.

“We made a bet on private investment grade,” Marc Rowan, Apollo’s chief executive, told a conference this month. “We are also a beneficiary of this de-banking of the world because the assets that we need . . . were the kinds of things that used to go on to the balance sheets of banks, investment-grade private credit.”

Apollo is not alone.
KKR in 2021 bought a majority stake in insurer Global Atlantic, adding $90bn to the group’s assets at the time.
Carlyle purchased just under a fifth of reinsurer Fortitude Re from AIG in 2018 before striking a new deal last year that reduced its stake but boosted Carlyle’s assets by about $50bn. Blackstone, meanwhile, invests on behalf of insurers such as Corebridge through its insurance solutions division.

The insurance units are required by state regulators to invest the vast majority of their holdings in investment-grade rated debt, to safeguard policyholders.

But unlike traditional insurers, alternative investment managers have been more comfortable using financial wizardry to design private transactions that can provide a few extra percentage points of return compared to traditional investment-grade corporate bonds, which yield about 5.5 per cent.

That can prove attractive to companies needing to raise cash without tapping the investment-grade bond market, particularly when issuing more debt at the corporate level would influence a business’s credit rating.

The deals have taken several different forms, but often a company will move some assets — perhaps a manufacturing facility or real estate portfolio — to a subsidiary or new special purpose vehicle. Then companies raise preferred equity or debt against the unit, which brings in cash the parent can use to run its day-to-day business.

Rating agencies typically treat preferred stock deals more favourably than run-of-the-mill loans. And often, because the equity is raised in a special purpose vehicle, the parent company does not have to report it on its balance sheet.

Apollo bought $2bn of AT&T preferred stock in a deal that allowed the wireless carrier to partially repay some of its outstanding preferred equity. That followed a $1bn investment in German real estate group Vonovia in a similar structure.

The investment giant has done a handful of other well-known private financings, including for AB InBev — a deal secured by the brewer’s plants — as well as for car rental provider Hertz and the Abu Dhabi National Oil Company.

Other deals, such as KKR’s agreement last week to purchase up to €40bn of consumer loans originated by PayPal, have more closely resembled traditional asset-backed securities. In those transactions, a pool of assets — such as mortgages, credit card receivables or auto loans — are packaged together, with the interest payments funding new slices of debt that are sold on to investors.

The use of insurance capital and private credit is just the latest example of blue-chip companies pairing up with alternative asset managers.

Intel last year struck a $30bn deal with Brookfield and its infrastructure funds, with the asset manager investing $15bn in a new chip foundry.

Intel, like most companies entering into these agreements, did not say how much it would pay Brookfield for the investment. However, its chief financial officer David Zinsner told analysts last year that Brookfield would receive part of the cash flows the plant generates once it is operational, giving the investment firm a return somewhere between 4.4 per cent and 8.5 per cent.

“It will protect our strong balance sheet,” Zinsner said of the deal. “It allows us to tap into a new pool of capital while protecting our cash and debt capacity for future investments.”

>>> US Close Dow -0.04% S&P -0.45% Nasdaq -1.16%

Closing Stock Market Summary

The session started on a more upbeat note, but the three major indices all closed in negative territory. The S&P 500 and Nasdaq settled near their worst levels of the day while the Dow Jones Industrial Average closed just below its flat line.

Weak mega stocks, which were trading down due to ongoing consolidation efforts, were integral to index level performance. The Vanguard Mega Cap Growth ETF (MGK) closed with a 1.3% loss while the market-cap weighted S&P 500 fell 0.5%.

Tesla (TSLA 241.05, -15.55, -6.1%), which was downgraded to Neutral from Buy at Goldman Sachs, and Alphabet (GOOG 119.09, -3.93, -3.2%), which was downgraded to Neutral from Buy at UBS, were some of the worst performers from the space. 

There was some underlying strength, though, as evidenced by the 0.6% gain in the Invesco S&P 500 Equal Weight ETF (RSP). Also, small and mid cap stocks were relative outperformers. The Russell 2000 closed with a modest 0.1% gain and the S&P Mid Cap 400 rose 0.8%. 

Roughly half of the 11 S&P 500 sectors closed with gains. Real estate (+2.2%) led the pack by a wide margin followed by energy (+1.7%) and materials (+1.0%). Meanwhile, the communication services (-1.9%), consumer discretionary (-1.3%), and information technology (-1.0%) sectors fell to the bottom of the pack, dragged down by their respective mega cap components. 

The consumer discretionary sector was also weighed down by a sizable loss in Carnival Corp. (CCL 14.60, -1.20, -7.6%). CCL had risen 80% since late April, but lost ground today after an earnings report that was better than expected.

In other corporate news, Dow component IBM (IBM 131.34, +1.91, +1.5%) agreed to buy Apptio for $4.6 billion cash.

Other factors driving the mixed price action, aside from weak mega caps and consolidation efforts, included some possible quarter-end rebalancing in favor of bonds, along with some geopolitical angst.

That geopolitical angst was part of the market narrative due to reports over the weekend indicating that Yevgeny Prigozhin, leader of the mercenary Wagner Group, led an incursion into Russia that has been described as a coup attempt. It ended quickly, though, after Prigozhin accepted asylum in Belarus. 

Treasuries settled with gains. The 2-yr note yield fell one basis point to 4.74% and the 10-yr note yield fell two basis points to 3.72%.

  • Nasdaq Composite: +27.4% YTD
  • S&P 500: +12.7% YTD
  • Russell 2000: +3.5% YTD
  • S&P Midcap 400: +4.3% YTD
  • Dow Jones Industrial Average: +1.7% YTD

There was no U.S. economic data of note today, but it's a busy week of data that will culminate with the release of the Personal Income and Spending report at 8:30 a.m. ET on Friday that will feature the Fed's preferred inflation gauge (the PCE and core-PCE Price Indices).

Looking ahead to Tuesday, market participants will receive the following economic data:

  • 8:30 ET: May Durable Orders (consensus -1.0%; prior 1.1%) and Durable Orders -ex transportation ( consensus 0.0%; prior -0.2%)
  • 9:00 ET: April FHFA Housing Price Index (prior 0.6%) and April S&P Case-Shiller Home Price Index (Briefing.com consensus -2.5%; prior -1.1%)
  • 10:00 ET: June Consumer Confidence ( consensus 103.8; prior 102.3) and May New Home Sales ( consensus 665,000; prior 683,000)

>>> US After Hours Summary: AEL +7.3% up after Brookfield nears deal to buyout f

After Hours Summary: AEL +7.3% up after Brookfield nears deal to buyout firm, according to Bloomberg; APLD -5.2% down after guiding MayQ revs below consensus

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: ABCM +2.9% (guidance)

Companies trading higher in after hours in reaction to news: AEL +7.3% (Brookfield nearing deal to acquire firm, according to Bloomberg), MOD +4.7% (Director sold $560K of stock), TERN +3% (new preclinical data for TERN-601), EWTX +2.8% (positive 12-month topline results from ARCH open label study), MLTX +2.6% (commences $250 mln public offering), EXPI +1.4% (increases repurchase cap by $500 mln), FTI +1.1% (awarded contract by Azule Energy), ALDX +1.1% (to announce resuilts from ADX-629), MBLY +0.6% (CFO steps down), HOOD +0.6% (cutting 7% of its workforce, according to WSJ), ILMN +0.2% (reducing workforce), MSFT +0.1% (considered acquiring Bungie and Sega, according to The Verge)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: APLD -5.2% (guidance)

Companies trading lower in after hours in reaction to news: ACET -14.4% (positive data from ADI-001 Phase 1), IDYA -1.1% (files mixed shelf), LTHM -0.1% (provides update on manufacturing facility fire), MTX -0.1% (subsidiary exiting talc business)

TEchCrunch : Databricks picks up MosaicML, an OpenAI competitor, for $1.3B

Databricks picks up MosaicML, an OpenAI competitor, for $1.3B

Investors aren’t the only ones who want to get their hands on hot tech companies in the field of AI: It’s also likely to spur a big wave of M&A, too. Today, Databricks announced it will pay $1.3 billion to acquire MosaicML, an open source startup with neural networks expertise that has built a platform for organizations to train large language models and deploy generative AI tools based on them.

Prior to this, MosaicML had raised just under $64 million from investors that included DCVC, AME Cloud Ventures, Lux, Frontline, Atlas, Playground Global and Samsung Next.

Notably, its last investor-round valuation was just $222 million — meaning it’s leaped 6x with this exit, a remarkable price that really does underscore just how frothy the AI market is right now, as well as the demand for talent and tech in the space.

Frothy, but only relatively speaking, considering that competitor OpenAI was valued at upwards of $40 billion in its last round from Microsoft.
In that context, Databricks got a steal here.

The deal will see MosaicML become a part of the Databricks Lakehouse Platform, providing generative AI tooling alongside the Databricks’ existing multicloud offerings, which include integration, storage, processing, governance, sharing, analytics and AI-related services.

The world is abuzz these days about OpenAI, and specifically the potential for where to apply the generative AI that OpenAI has popularized and made very accessible.
But inevitably the Microsoft-backed parent of ChatGPT is not working in a vacuum, and others are emerging and growing to capitalize on the surge of interest in the space.

MosaicML is no slouch in that regard. The penultimate version of its LLM, MPT-7B, has had 3.3 million downloads.

WWD : Fewer Young Women Carrying Handbags These Days, According to Circana Study

Fewer Young Women Carrying Handbags These Days, According to Circana Study

The $8.8 billion handbag market in the U.S. market is facing a generational dilemma. Younger women are less likely than older women to buy and carry handbags, according to an Omnibus survey from Circana, the new company that combined IRI and The NPD Group.

The study found that more than 60 percent of women ages 35 and older report that they always carry a handbag for activities, other than work or school, compared to only 39 percent of women ages 18 to 34.

When younger women do buy bags, they’re more apt to purchase tote bags; shoppers; fanny, waist and chest packs; backpacks, and small crossbody styles, the survey found.

According to Circana’s Checkout, its receipt-based tracking service, which recently expanded to include data for the U.S. accessories market, consumers between the ages of 18 and 34 years old are purchasing fewer handbags than older shoppers. Among younger consumers, unit sales dropped 2 percent year-over-year in the 12 months ending April. Units grew by 7 percent among older consumers versus the prior year. Consumers aged 35 and older also helped offset some of the industry’s year-over-year sales revenue losses.

“Brands and retailers can narrow this generational gap by tailoring their products and marketing messages to the lifestyles of younger consumers,” said Beth Goldstein, footwear and accessories analyst at Circana.
“Millennials and Gen Z are seeking both function and fashion, as they embark on their daily activities, special events and travel, so they are looking for products that provide ease and convenience.
Versatile, hands-free options, including backpacks and fanny packs, have proven to be very desirable.”
While 18- to 34-year-olds accounted for a decline in the overall handbag market over the past year, sales from certain styles grew for this age group. For example, totes and shoppers were up 11 percent; fanny, waist and chest packs increased 56 percent, and everyday lifestyle backpacks rose 7 percent. Small crossbody bags are the most frequently carried style. Young women are also more likely to carry backpacks, according to the Omnibus survey results.

When Millennial and Gen Z shoppers do buy bags, they’re buying more frequently in directly owned stores or specialty retailers, Circana’s data shows.

“While department stores and major e-commerce players remain the top channels for handbag purchases overall, younger consumers are gravitating to specialty stores that offer newness and innovation, particularly aligned with the prominence of athleisure,” Goldstein said. “From the handbag styles they are buying to where they are shopping, understanding the purchase motives by generation and harnessing the power of these contrasts should be key brand and retailer initiatives,” she said.

WWD : Kering Beauté Acquires Creed

Kering Beauté Acquires Creed
The French luxury group is building up its beauty division.

PARIS — Kering Beauté has made its first acquisition: Creed.

The French luxury house said Monday that it has purchased the totality of the high-end niche fragrance house that’s controlled by BlackRock Long Term Private Capital Europe and the current chairman Javier Ferrán.

Financial terms of the all-cash transaction were not disclosed.

Creed will join other perfume brands in Kering Beauté’s stable that include Bottega Veneta, Balenciaga, Alexander McQueen, Pomellato and Qeelin.

Creed is the first niche fragrance brand to be owned by Kering, which announced early this year that it was creating an in-house beauty division.

The high-end luxury fragrance segment is a hot commodity these days, among the fastest growing in beauty. It’s been registering double-digit growth, plus high profitability and revenue recurrence.

Creed dates back to 1760, when it was begun by James Henry Creed during the reign of King George III of England. Creed was first established as a tailor and later a fragrance house. Over the years, the Creed family produced more than 200 perfumes, including the cult bestselling men’s fragrance Aventus Cologne, Viking, Himalaya and Green Irish Tweed.

Based in Paris, with a factory in nearby Fontainebleau, Creed manufactures many of its own essences using a traditional infusion technique that enables Creed to maintain the quality and authenticity of its fragrances.

In a statement Kering called Creed is the largest global indie high-end fragrance-maker.

Creed was sold by the Creed family to BlackRock and Ferrán in early 2020, when industry sources estimated that Creed’s revenues were in excess of $200 million.

“The acquisition of Creed is a major step for Kering Beauté,” Kering said in a statement. “A perfect fit with its portfolio of renowned luxury brands, it immediately provides Kering Beauté with the required scale, an outstanding financial profile, as well as a platform, supporting the future development of other Kering Beauté fragrance franchises, by leveraging in particular Creed’s global distribution network.”

Kering Beauté said that while maintaining the heritage and high-end image of Creed, it will further unlock the brand’s potential in all markets, channels and categories, especially via its development in China and travel retail, as well as expand further in the feminine fragrance portfolio, body and home categories.

“The beauty category is a natural extension of Kering’s luxury universe, and the group is confident its expansion in this strategic segment will create lasting value for the group and its houses,” Kering said.

The deal is expected to close in the second half of this year.

“The acquisition of Creed represents Kering Beauté’s first strategic initiative, and demonstrates our commitment to developing a strong position in the luxury beauty segment,” said François-Henri Pinault, chairman and chief executive officer of Kering, in a statement.

“I am thrilled that today our stories and values come together around this spirit of family entrepreneurship and excellence to accelerate our journey in beauty, and I am delighted that the brand is joining Kering’s collection of luxury houses,” he said.

“The House of Creed is recognized as one of the few leading global luxury fragrance brands, synonymous with exclusivity and creativity,” said Jean-François Palus, group managing director of Kering. “We are confident that this landmark acquisition will facilitate and amplify our development in fragrance.
This is a milestone in the development of Kering Beauté, as we believe more than ever in the strong potential of our brands in beauty.”

After months of speculation, Kering in early February said it has begun taking its beauty business back in-house, and that it had appointed Raffaella Cornaggia as CEO of Kering Beauté, a new position in a new division.

She reports to Palus and has been charged with developing with a team an expertise in the beauty category for Bottega Veneta, Balenciaga, Alexander McQueen, Pomellato and Qeelin.

At the time, Kering said: “The creation of Kering Beauté will enable the group to support these brands in the development of the beauty category, which is a natural extension of their universe.”

Until then the buzz had been intensifying about whether Kering would make such a move and if so, what that might take, especially in regards to jewels in the crown, Gucci and Yves Saint Laurent, which are licensed to Coty Inc. and L’Oréal, respectively.

Kering is no stranger to beauty. Until the late 2000s, the group, then called PPR, took a more hands-on approach to fragrance and cosmetics. At the time, PPR’s Gucci Group had a beauty subsidiary named YSL Beauté, which included fragrance and beauty brands and licenses, such as Yves Saint Laurent, Stella McCartney, Boucheron and Ermenegildo Zegna, before it was sold to L’Oréal in 2008 for 1.15 billion euros.

Today, Gucci has a 50-year beauty license that is held by Coty and expected to expire in 2028. The Yves Saint Laurent license with L’Oréal is long term.

Among Kering’s other owned fashion and jewelry labels, Interparfums runs Boucheron’s business in perfume, while Lalique Group develops Brioni’s fragrance activity.

Industry experts believe it makes good strategic sense for Kering to sharpen its focus on beauty, especially as the group now has a stronger balance sheet and net cash position with which to carry out deals.

But Kering Beauté is up against some formidable competitors.
LVMH — which has 15 brands, including Parfums Cristian Dior and Guerlain, in its Perfumes and Cosmetics division — in March reorganized that branch, naming Stéphane Rinderknech as its chairman and CEO.
There had been no one executive helming that division for decades.

According to WWD Beauty Inc’s Top 100 Ranking of beauty manufacturers, reflecting 2022 sales, LVMH placed sixth, Shiseido fifth, Procter & Gamble fourth, the Estée Lauder Cos. third, Unilever second and L’Oréal first.

Luxury goods companies, such as Puig, have over the past decade been taking back full control of the brands they own. That can pack a powerful punch, giving them more consistency, synergies and power.

There is something of an an arms race today to acquire and invest in niche fragrance brands.
The category has been the biggest driver in the premium fragrance segment, which grew 9.1 percent to $57.36 billion and is forecast to rise another 7.9 percent between 2022 and 2023, and 6.7 percent between 2023 and 2024, according to Euromonitor International.

Last week, Advent International acquired Parfums de Marly and Initio Parfums Privés in a deal estimated by industry sources to be more than $700 million. Also this month, a majority stake in Sabé Masson, which began with solid fragrances, was sold to Boris Gratini et Hélène Ortola.

In May, Juliette Has a Gun raised a new round of funding with Cathay Capital, as did Perfumer H, with Natura & Co.’s venture capital fund Fable Investments.

TAGS

WSJ : Amedisys Agrees to UnitedHealth Takeover, Scraps Option Care Health Merger

Amedisys Agrees to UnitedHealth Takeover, Scraps Option Care Health Merger
Unsolicited offer from UnitedHealth outbids $2.8 billion deal

UnitedHealth Group UNH 0.77%increase; green up pointing triangle will acquire Amedisys AMED -0.23%decrease; red down pointing triangle for $101 a share, or nearly $3.29 billion, upending a prior deal for the home-health provider to combine with Option Care Health OPCH 4.83%increase; green up pointing triangle.

Amedisys said Monday that it has agreed to a takeover by UnitedHealth’s Optum health-services arm in which each Amedisys share will be converted into the right to $101 in cash.

Amedisys will become a wholly owned subsidiary of UnitedHealth when the transaction is completed.
UnitedHealth’s UnitedHealthcare is the biggest U.S. health insurer.
Its Optum business includes a sprawling network of physician groups, surgery centers and other assets.

Paul Kusserow, the chairman and former chief executive of Amedisys, said the UnitedHealth deal “gives us the opportunity to continue to significantly innovate driving care into the home with a like-minded partner who brings a set of unique and additive capabilities to the table.”

A spokeswoman for UnitedHealth declined to comment.

The companies didn’t provide an expected closing date on the acquisition, which still needs to be approved by regulators and Amedisys shareholders.

The combination is likely to draw close antitrust scrutiny from the Federal Trade Commission. Optum will be seeking to take over the No. 2 competitor in the home-health business, after recently absorbing the No. 3 company, according to analysts.

The Biden administration has signaled concern about tie-ups between related businesses in an industry. The Justice Department earlier challenged Optum’s acquisition of health-technology company Change Healthcare, but a judge ruled against the antitrust enforcers and the deal went through.

When it announced its offer for Amedisys, UnitedHealth said it was confident it could secure approval for the combination, partly because of how fragmented the home-health business is.

Analysts have said that the combination of Optum’s current home-health assets and Amedisys would only comprise about 10% or less of the industry and suggested that the companies would have to offer divestitures to close the deal, likely in the Southeast and mid-Atlantic regions.

The deal can be terminated if it isn’t completed within one year, or 18 months if an extension is granted, according to a securities filing.

If Amedisys lands a better deal and scraps the UnitedHealth merger, the company would owe UnitedHealth a $125 million termination fee under the terms of Monday’s agreement. Alternatively, UnitedHealth would owe Amedisys a $144 million termination fee if the merger is blocked by antitrust regulators.

Earlier this month, Baton Rouge, La.-based Amedisys said it had received an unsolicited proposal from the UnitedHealth unit for an acquisition at $100 a share, which represented a nearly 26% premium to the stock’s most recent closing price at the time.

The new bid disrupted Amedisys’s plans to merge with Option Care Health in an all-stock transaction that was announced in May.

The Option Care Health deal was valued at roughly $2.8 billion, or $86.29 a share, to Amedisys investors when UnitedHealth made its competing offer. Amedisys’s directors said at the time that the new offer likely represented a better deal than the Option Care Health agreement.

Under their contract terms, Amedisys is set to pay Option Care Health a $106 million termination fee, which the latter company said will be incorporated into its existing capital-allocation strategy.

Shares of UnitedHealth were up slightly in midday trading, while shares of Amedisys were down about 1% and Option Care Health were up more than 5%.

FT : SES-imagotag/Gotham: racy pricing helps short seller inflict shelf harm

SES-imagotag/Gotham: racy pricing helps short seller inflict shelf harm
The path back to a premium valuation will be tricky even after a detailed riposte

Mockney wheeler dealer “Del Boy” Trotter was known for his French language faux pas and council flat in Nelson Mandela House, London. By mere coincidence, SES-imagotag resides in Nelson Mandela Place, Paris.

Its detailed counterblast against claims made by short seller Gotham City avoided any gaffes in English. But they will not leave international investors comprehensively reassured.

The riposte from the internet-of-things company reduced rather than wiped out a drop in the shares of almost 60 per cent at the end of last week. Gotham says revenues and ebitda are overstated. The path back to a premium valuation will be tricky.

SES makes and sells electronic shelf labels for retailers.
They are a handy way for brick and mortar shops to digitise. Sales have exploded in recent years from €250mn in 2019 to a forecast of more than €800mn this year. SES’s compound annual growth rate of 27 per cent easily beats listed peers Pricer of Sweden and Korea’s Solum.

Gotham says related party transactions boost SES-imagotag revenues via a circular chain. The company strongly denies this.

Aggressive accounting policies do not help SES’s wider cause. The company capitalises a lot more of its research and development spend as a share of revenues than Pricer.
Free cash flow remains negative and fails to reflect ebitda growth in recent years.
SES blames large investments.

The cash shortfall should be a red flag for shareholder regardless. Similar complaints led by short seller Muddy Waters hit the highly-valued shares of legal financier Burford in 2019.

Before Gotham’s attack, SES shares had risen fivefold in five years. On a price to sales multiple SES’s valuation was at a substantial premium to peers and well above the gap applying to price to earnings multiples. 

Del Boy’s ride was a Reliant Robin, a vehicle famed for overbalancing when manoeuvring at speed. Something similar has happened to SES. Gotham’s more lurid claims are disputed. But SES’s accounting has clearly been too racy. The price correction is merited.

FT : New York office market bolstered by sale valuing tower at $2bn

New York office market bolstered by sale valuing tower at $2bn
SL Green shares jump 20% after deal with Japan’s Mori Trust for stake in Park Avenue building

New York City’s largest office landlord has agreed to sell a stake in a prominent tower that gives it a $2bn valuation, a modest markdown from its previous price that came as a relief to a commercial property market beset by vacancies.

SL Green will sell the 49.9 per cent stake in Manhattan’s 245 Park Avenue building to Japan’s Mori Trust, supplying much-needed cash to the real estate investment trust.

The deal announced on Monday is one of the largest New York City office transactions since the US Federal Reserve began raising interest rates in March 2022, hastening a downturn for the office sector precipitated by remote working.

SL Green has been a particular victim: Its shares fell from more than $80 last March to dip below $20 earlier this year. On Monday, they jumped 20.5 per cent to $28.39.

Harrison Sitomer, SL Green’s chief investment officer, said its Park Avenue properties were still commanding robust rents in spite of the broader market turmoil. He also predicted more deals would be in the offing, with foreign investors such as Mori searching for bargains in the world’s largest office market.

“There’s been a notable momentum shift for groups wanting to find product in New York,” he said, citing growing inquiries from potential partners. “Investors that are well-capitalised are going to continue to see opportunity in New York.”

Other real estate executives were heartened by the valuation, which approached the $2.2bn that China’s HNA Group paid for 245 Park in 2017 when the market was near its peak. They also saw it as proof that choice New York office properties still appealed to foreign investors.

“Rumours of New York’s demise are greatly exaggerated,” wrote Ruth Colp-Haber of Wharton Property Advisors, calling the deal “an unmistakably positive development”.

The 245 Park building was built in 1967 and hosts businesses including the investment managers Ares Capital and Angelo Gordon. While it boasts a prime address across the street from Grand Central Station, it has been shedding crucial tenants in recent years and was in need of renovation.

SL Green announced a plan for a revamp, including new lobbies and amenities, when it bought the building out of bankruptcy last year following a dispute with HNA, its one-time partner. As part of that deal, SL Green assumed $1.76bn in mortgage and mezzanine loans attached to the property, which come due in 2027.

Monday’s transaction contrasted with the gloom hanging over office towers and their owners since the Covid-19 pandemic accelerated a trend towards remote working. In many US cities, office occupancy has hovered around 50 per cent, prompting tenants to dump space on the sublease market and landlords to reduce rents.

The newest and most advanced buildings, such as SL Green’s One Vanderbilt, have defied those trends and continued to command record rents. Older buildings, however, have fallen out of favour, with some owners handing them back to lenders.

A recent study by broker JLL found that office buildings in New York had lost $76bn from their most recent sales prices.

Uncertainty about the prospects for offices and rising rates has damped investment activity. The volume of office transactions in US central business districts was down 70 per cent in May compared with May 2020, according to MSCI Real Capital Analytics.